Estimated glomerular filtration ratio is a better index than creatinine clearance (Cockcroft–Gault) for predicting the prevalence of atrial fibrillation in the general Japanese population
Direct oral anti-coagulants (DOACs) have been used in patients with non-valvular atrial fibrillation (AF), and renal function evaluation using the CCr (Cockcroft-Gault) is recommended as a criterion for the reduction of DOAC. In contrast, estimated glomerular filtration rate (eGFR) is usually used a...
Saved in:
Published in | Hypertension research Vol. 41; no. 6; pp. 451 - 459 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Nature Publishing Group
01.06.2018
|
Subjects | |
Online Access | Get full text |
ISSN | 0916-9636 1348-4214 1348-4214 |
DOI | 10.1038/s41440-018-0032-6 |
Cover
Abstract | Direct oral anti-coagulants (DOACs) have been used in patients with non-valvular atrial fibrillation (AF), and renal function evaluation using the CCr (Cockcroft-Gault) is recommended as a criterion for the reduction of DOAC. In contrast, estimated glomerular filtration rate (eGFR) is usually used as an index of renal function in daily practice. We determined the age- and gender-specific prevalence rates of AF and whether CCr or eGFR was associated with the prevalence of AF. Data from the periodic health examinations of 108,951 subjects were collected. Risk factors for AF were determined based on medical history, physical examinations and blood samples, and AF was diagnosed based on electrocardiography. The prevalence rate of AF was 0.92% (998/108,951). It was four times higher in men than in women and increased with age. Cardiac disease (odds ratio (OR) = 27.07, confidence interval (CI) 23.39-31.37, p = 0.0001), male gender (OR = 3.65, CI 3.11-4.30), age > 65 years (OR = 2.52, CI 2.14-2.96), hyperlipidemia (OR = 2.51, CI 1.97-3.20), BMI > 25 kg/m
(OR = 1.37, CI 1.19-1.58) and hypertension (OR = 1.14, CI 1.11-1.16) were independently associated with a high risk of AF in the multivariate logistic regression analysis. The odds ratio of having AF was significantly higher in patients with eGFR ≤ 59 (OR = 2.10, CI 1.21-3.86) than in those with eGFR ≥ 90 but was not associated with CCr after adjustments for age, gender, diabetes mellitus and smoking. The significance of this difference disappeared after additional adjustment for hypertension. Cardiac disease, gender, age, hyperlipidemia, obesity, hypertension and renal dysfunction were strong risk factors for AF. The evaluation of renal dysfunction as a morbidity risk factor for AF suggests that eGFR should be used. |
---|---|
AbstractList | Direct oral anti-coagulants (DOACs) have been used in patients with non-valvular atrial fibrillation (AF), and renal function evaluation using the CCr (Cockcroft-Gault) is recommended as a criterion for the reduction of DOAC. In contrast, estimated glomerular filtration rate (eGFR) is usually used as an index of renal function in daily practice. We determined the age- and gender-specific prevalence rates of AF and whether CCr or eGFR was associated with the prevalence of AF. Data from the periodic health examinations of 108,951 subjects were collected. Risk factors for AF were determined based on medical history, physical examinations and blood samples, and AF was diagnosed based on electrocardiography. The prevalence rate of AF was 0.92% (998/108,951). It was four times higher in men than in women and increased with age. Cardiac disease (odds ratio (OR) = 27.07, confidence interval (CI) 23.39-31.37, p = 0.0001), male gender (OR = 3.65, CI 3.11-4.30), age > 65 years (OR = 2.52, CI 2.14-2.96), hyperlipidemia (OR = 2.51, CI 1.97-3.20), BMI > 25 kg/m
(OR = 1.37, CI 1.19-1.58) and hypertension (OR = 1.14, CI 1.11-1.16) were independently associated with a high risk of AF in the multivariate logistic regression analysis. The odds ratio of having AF was significantly higher in patients with eGFR ≤ 59 (OR = 2.10, CI 1.21-3.86) than in those with eGFR ≥ 90 but was not associated with CCr after adjustments for age, gender, diabetes mellitus and smoking. The significance of this difference disappeared after additional adjustment for hypertension. Cardiac disease, gender, age, hyperlipidemia, obesity, hypertension and renal dysfunction were strong risk factors for AF. The evaluation of renal dysfunction as a morbidity risk factor for AF suggests that eGFR should be used. Direct oral anti-coagulants (DOACs) have been used in patients with non-valvular atrial fibrillation (AF), and renal function evaluation using the CCr (Cockcroft-Gault) is recommended as a criterion for the reduction of DOAC. In contrast, estimated glomerular filtration rate (eGFR) is usually used as an index of renal function in daily practice. We determined the age- and gender-specific prevalence rates of AF and whether CCr or eGFR was associated with the prevalence of AF. Data from the periodic health examinations of 108,951 subjects were collected. Risk factors for AF were determined based on medical history, physical examinations and blood samples, and AF was diagnosed based on electrocardiography. The prevalence rate of AF was 0.92% (998/108,951). It was four times higher in men than in women and increased with age. Cardiac disease (odds ratio (OR) = 27.07, confidence interval (CI) 23.39-31.37, p = 0.0001), male gender (OR = 3.65, CI 3.11-4.30), age > 65 years (OR = 2.52, CI 2.14-2.96), hyperlipidemia (OR = 2.51, CI 1.97-3.20), BMI > 25 kg/m2 (OR = 1.37, CI 1.19-1.58) and hypertension (OR = 1.14, CI 1.11-1.16) were independently associated with a high risk of AF in the multivariate logistic regression analysis. The odds ratio of having AF was significantly higher in patients with eGFR ≤ 59 (OR = 2.10, CI 1.21-3.86) than in those with eGFR ≥ 90 but was not associated with CCr after adjustments for age, gender, diabetes mellitus and smoking. The significance of this difference disappeared after additional adjustment for hypertension. Cardiac disease, gender, age, hyperlipidemia, obesity, hypertension and renal dysfunction were strong risk factors for AF. The evaluation of renal dysfunction as a morbidity risk factor for AF suggests that eGFR should be used.Direct oral anti-coagulants (DOACs) have been used in patients with non-valvular atrial fibrillation (AF), and renal function evaluation using the CCr (Cockcroft-Gault) is recommended as a criterion for the reduction of DOAC. In contrast, estimated glomerular filtration rate (eGFR) is usually used as an index of renal function in daily practice. We determined the age- and gender-specific prevalence rates of AF and whether CCr or eGFR was associated with the prevalence of AF. Data from the periodic health examinations of 108,951 subjects were collected. Risk factors for AF were determined based on medical history, physical examinations and blood samples, and AF was diagnosed based on electrocardiography. The prevalence rate of AF was 0.92% (998/108,951). It was four times higher in men than in women and increased with age. Cardiac disease (odds ratio (OR) = 27.07, confidence interval (CI) 23.39-31.37, p = 0.0001), male gender (OR = 3.65, CI 3.11-4.30), age > 65 years (OR = 2.52, CI 2.14-2.96), hyperlipidemia (OR = 2.51, CI 1.97-3.20), BMI > 25 kg/m2 (OR = 1.37, CI 1.19-1.58) and hypertension (OR = 1.14, CI 1.11-1.16) were independently associated with a high risk of AF in the multivariate logistic regression analysis. The odds ratio of having AF was significantly higher in patients with eGFR ≤ 59 (OR = 2.10, CI 1.21-3.86) than in those with eGFR ≥ 90 but was not associated with CCr after adjustments for age, gender, diabetes mellitus and smoking. The significance of this difference disappeared after additional adjustment for hypertension. Cardiac disease, gender, age, hyperlipidemia, obesity, hypertension and renal dysfunction were strong risk factors for AF. The evaluation of renal dysfunction as a morbidity risk factor for AF suggests that eGFR should be used. Direct oral anti-coagulants (DOACs) have been used in patients with non-valvular atrial fibrillation (AF), and renal function evaluation using the CCr (Cockcroft–Gault) is recommended as a criterion for the reduction of DOAC. In contrast, estimated glomerular filtration rate (eGFR) is usually used as an index of renal function in daily practice. We determined the age- and gender-specific prevalence rates of AF and whether CCr or eGFR was associated with the prevalence of AF. Data from the periodic health examinations of 108,951 subjects were collected. Risk factors for AF were determined based on medical history, physical examinations and blood samples, and AF was diagnosed based on electrocardiography. The prevalence rate of AF was 0.92% (998/108,951). It was four times higher in men than in women and increased with age. Cardiac disease (odds ratio (OR) = 27.07, confidence interval (CI) 23.39–31.37, p = 0.0001), male gender (OR = 3.65, CI 3.11–4.30), age > 65 years (OR = 2.52, CI 2.14–2.96), hyperlipidemia (OR = 2.51, CI 1.97–3.20), BMI > 25 kg/m2 (OR = 1.37, CI 1.19–1.58) and hypertension (OR = 1.14, CI 1.11–1.16) were independently associated with a high risk of AF in the multivariate logistic regression analysis. The odds ratio of having AF was significantly higher in patients with eGFR ≤ 59 (OR = 2.10, CI 1.21–3.86) than in those with eGFR ≥ 90 but was not associated with CCr after adjustments for age, gender, diabetes mellitus and smoking. The significance of this difference disappeared after additional adjustment for hypertension. Cardiac disease, gender, age, hyperlipidemia, obesity, hypertension and renal dysfunction were strong risk factors for AF. The evaluation of renal dysfunction as a morbidity risk factor for AF suggests that eGFR should be used. |
Author | Horinaka, Shigeo Shirakawa, Chiaki Kogure, Yoshio Yonezawa, Yutaka |
Author_xml | – sequence: 1 givenname: Yutaka surname: Yonezawa fullname: Yonezawa, Yutaka – sequence: 2 givenname: Shigeo surname: Horinaka fullname: Horinaka, Shigeo – sequence: 3 givenname: Chiaki surname: Shirakawa fullname: Shirakawa, Chiaki – sequence: 4 givenname: Yoshio surname: Kogure fullname: Kogure, Yoshio |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29559690$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kktuFDEQhi0URCaBA7BBltiERYNf3W0v0SgEUCQ2sLbc7urBwWM3tjuCHXfgPFyGk-CZTjaRWJWs-v56uP4zdBJiAISeU_KaEi7fZEGFIA2hsiGEs6Z7hDaUC9kIRsUJ2hBFu0Z1vDtFZznfEMJkq-gTdMpU26pOkQ36c5mL25sCI975uIe0eJPw5HxJprgY8DFgl7HBA5QCCbswwg9cvpqAbYKaDi4Ath5MMsECvthG-82mOJW_v35fmcWXV3iKCc8JRmcrvqtiODxvjYeDIk7YlOSMr42H5LxfW7twBHcQINXcRzObALkq47ysyFP0eDI-w7O7eI6-vLv8vH3fXH-6-rB9e91YLlRpjGpZx5Ude86UMCMBCnboacus6STlRClCjJCtZIQrKhSzba96OXDKGGkNP0cXa905xe8L5KL3LluogwaIS9aM0K7lrJNtRV8-QG_ikkKdrlJCSUkF7Sv14o5ahj2Mek71COmnvj9MBfoVqB-Zc4JJW1eOO9fDOK8p0QcL6NUCulpAHyygu6qkD5T3xf-v-QdRgLXw |
CitedBy_id | crossref_primary_10_1038_s41440_019_0384_6 crossref_primary_10_1681_ASN_2020030301 crossref_primary_10_1016_j_lanwpc_2022_100439 crossref_primary_10_1007_s00059_023_05181_7 crossref_primary_10_1016_j_mce_2020_110984 crossref_primary_10_1007_s40256_022_00560_7 crossref_primary_10_1253_circj_CJ_20_0329 crossref_primary_10_2147_VHRM_S284248 |
Cites_doi | 10.1056/NEJMoa1107039 10.1093/ejechocard/jen117 10.1001/jama.292.20.2471 10.1053/j.ajkd.2010.02.344 10.1016/j.amjcard.2010.06.030 10.1161/01.CIR.101.18.2200 10.1001/jama.285.18.2370 10.1371/journal.pone.0155581 10.1159/000180580 10.1053/j.ajkd.2008.12.034 10.7326/0003-4819-130-6-199903160-00002 10.1056/NEJMoa041031 10.1056/NEJMoa1009638 10.1681/ASN.2013040361 10.1161/HYPERTENSIONAHA.111.179713 10.1371/journal.pone.0079717 10.1016/j.ahj.2009.06.031 10.4070/kcj.2016.46.4.515 10.1177/0091270011409231 10.1056/NEJMoa0905561 10.1056/NEJMoa1007432 10.1253/circj.CJ-11-1134 10.1592/phco.30.8.776 10.1161/01.CIR.96.7.2455 10.1056/NEJMoa1105594 10.1016/S0140-6736(09)61340-4 10.1093/eurheartj/ehs274 10.1093/ndt/gfs607 10.1253/circj.CJ-11-0780 10.1016/j.jacc.2010.02.029 10.1093/eurheartj/eht328 10.1093/ndt/gft006 10.1053/j.ajkd.2010.02.337 10.1016/j.ijcard.2008.06.029 10.1001/jama.1994.03510350050036 10.1371/journal.pone.0143205 10.1161/CIRCULATIONAHA.112.107128 10.1016/j.amjcard.2017.01.005 10.1016/j.amjcard.2008.06.018 10.1161/01.HYP.0000102971.85504.7c 10.1111/j.1532-5415.1985.tb07117.x |
ContentType | Journal Article |
Copyright | Copyright Nature Publishing Group Jun 2018 |
Copyright_xml | – notice: Copyright Nature Publishing Group Jun 2018 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 |
DOI | 10.1038/s41440-018-0032-6 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest One Academic Middle East (New) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1348-4214 |
EndPage | 459 |
ExternalDocumentID | 29559690 10_1038_s41440_018_0032_6 |
Genre | Journal Article Comparative Study |
GeographicLocations | Japan |
GeographicLocations_xml | – name: Japan |
GroupedDBID | --- -Q- 0R~ 29I 39C 4.4 406 53G 5GY 70F 7X7 88E 8FI 8FJ AACDK AANZL AASML AATNV AAYXX ABAKF ABBRH ABDBE ABFSG ABJNI ABLJU ABRTQ ABUWG ABZZP ACAOD ACGFO ACGFS ACKTT ACMJI ACRQY ACSTC ACZOJ ADBBV AEFQL AEJRE AEMSY AENEX AESKC AEVLU AEXYK AEZWR AFBBN AFDZB AFHIU AFKRA AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AHWEU AIGIU AILAN AIXLP AJRNO ALFFA ALMA_UNASSIGNED_HOLDINGS AMYLF ATHPR AXYYD AYFIA BENPR BKKNO BPHCQ BVXVI CCPQU CITATION CS3 DNIVK DPUIP DU5 E3Z EBLON EBS EE. EIOEI EJD F5P FDQFY FERAY FIGPU FIZPM FSGXE FYUFA GX1 HMCUK HZ~ IWAJR JSH JSO JZLTJ M1P NQJWS O9- OK1 P2P PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RNT RNTTT ROL SNX SNYQT SOHCF SOJ SRMVM SWTZT TAOOD TBHMF TDRGL TSG UKHRP XSB .55 2WC ABAWZ ALIPV BAWUL CGR CUY CVF DIK ECM EIF EMB EMOBN JSF KQ8 LGEZI LOTEE NADUK NPM NXXTH RJT RZJ SV3 TKC TR2 W2D X7M 3V. 7XB 8FK K9. PKEHL PQEST PQUKI 7X8 |
ID | FETCH-LOGICAL-c349t-a952639cd73294ad0e1ecb7152ca681309900a485820391492c57978b312205a3 |
IEDL.DBID | 7X7 |
ISSN | 0916-9636 1348-4214 |
IngestDate | Fri Sep 05 03:58:02 EDT 2025 Sat Sep 20 14:20:50 EDT 2025 Mon Jul 21 06:08:05 EDT 2025 Thu Apr 24 22:50:24 EDT 2025 Wed Oct 01 04:50:23 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c349t-a952639cd73294ad0e1ecb7152ca681309900a485820391492c57978b312205a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
PMID | 29559690 |
PQID | 2049881417 |
PQPubID | 2043497 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_2016532685 proquest_journals_2049881417 pubmed_primary_29559690 crossref_citationtrail_10_1038_s41440_018_0032_6 crossref_primary_10_1038_s41440_018_0032_6 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-06-01 |
PublicationDateYYYYMMDD | 2018-06-01 |
PublicationDate_xml | – month: 06 year: 2018 text: 2018-06-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Tokyo |
PublicationTitle | Hypertension research |
PublicationTitleAlternate | Hypertens Res |
PublicationYear | 2018 |
Publisher | Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group |
References | JB Olesen (32_CR5) 2012; 367 I Grundvold (32_CR26) 2012; 59 S Matsuo (32_CR37) 2009; 53 SJ Connolly (32_CR17) 2009; 361 TC Dowling (32_CR8) 2010; 30 AS Levey (32_CR36) 1999; 130 M Horio (32_CR45) 2010; 56 BM Psaty (32_CR2) 1997; 96 MR Patel (32_CR18) 2011; 365 P Delanaye (32_CR34) 2013; 28 S Matsuo (32_CR14) 2009; 53 Y Ohyama (32_CR39) 2013; 8 SJ Connolly (32_CR43) 2011; 364 S Harder (32_CR6) 2012; 52 M Abe (32_CR12) 2017; 119 AS Go (32_CR1) 2001; 285 UB Tedrow (32_CR24) 2010; 55 Y Iguchi (32_CR40) 2008; 102 MJ Sarnak (32_CR4) 2003; 42 S Apostolakis (32_CR10) 2013; 34 SH Hohnloser (32_CR9) 2012; 33 H Watanabe (32_CR29) 2011; 75 RL Schmidt (32_CR32) 2015; 10 EJ Benjamin (32_CR25) 1994; 271 MK Son (32_CR27) 2016; 46 W Shang (32_CR3) 2016; 11 TJ Wang (32_CR21) 2004; 292 Y Iguchi (32_CR30) 2010; 106 DW Cockcroft (32_CR16) 1976; 16 Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (32_CR15) 2013; 3 Z Harel (32_CR7) 2014; 25 CB Granger (32_CR19) 2011; 365 AS Levey (32_CR44) 2010; 55 CA Garza (32_CR22) 2008; 9 CB Granger (32_CR42) 2011; 365 SI Hallan (32_CR35) 2013; 28 HW Smith (32_CR38) 1951 H Watanabe (32_CR41) 2009; 158 H Inoue (32_CR20) 2009; 137 P Verdecchia (32_CR28) 2009; 374 JP Piccini (32_CR11) 2013; 127 AS Go (32_CR13) 2004; 351 S Suzuki (32_CR31) 2011; 75 F Bode (32_CR23) 2000; 101 RD Lindeman (32_CR33) 1985; 33 |
References_xml | – volume: 365 start-page: 981 year: 2011 ident: 32_CR19 publication-title: N Engl J Med doi: 10.1056/NEJMoa1107039 – volume: 9 start-page: 587 year: 2008 ident: 32_CR22 publication-title: Eur J Echocardiogr doi: 10.1093/ejechocard/jen117 – volume: 292 start-page: 2471 year: 2004 ident: 32_CR21 publication-title: JAMA doi: 10.1001/jama.292.20.2471 – start-page: 1 volume-title: The kidney: structure and functional in health and disease year: 1951 ident: 32_CR38 – volume: 56 start-page: 32 year: 2010 ident: 32_CR45 publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2010.02.344 – volume: 106 start-page: 1129 year: 2010 ident: 32_CR30 publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2010.06.030 – volume: 101 start-page: 2200 year: 2000 ident: 32_CR23 publication-title: Circulation doi: 10.1161/01.CIR.101.18.2200 – volume: 285 start-page: 2370 year: 2001 ident: 32_CR1 publication-title: JAMA doi: 10.1001/jama.285.18.2370 – volume: 11 start-page: e0155581 year: 2016 ident: 32_CR3 publication-title: PLoS ONE doi: 10.1371/journal.pone.0155581 – volume: 16 start-page: 31 year: 1976 ident: 32_CR16 publication-title: Nephron doi: 10.1159/000180580 – volume: 53 start-page: 982 year: 2009 ident: 32_CR14 publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2008.12.034 – volume: 130 start-page: 461 year: 1999 ident: 32_CR36 publication-title: Ann Intern Med doi: 10.7326/0003-4819-130-6-199903160-00002 – volume: 351 start-page: 1296 year: 2004 ident: 32_CR13 publication-title: N Engl J Med doi: 10.1056/NEJMoa041031 – volume: 365 start-page: 883 year: 2011 ident: 32_CR18 publication-title: N Engl J Med doi: 10.1056/NEJMoa1009638 – volume: 25 start-page: 431 year: 2014 ident: 32_CR7 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2013040361 – volume: 59 start-page: 198 year: 2012 ident: 32_CR26 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.111.179713 – volume: 8 start-page: e79717 year: 2013 ident: 32_CR39 publication-title: PLoS ONE doi: 10.1371/journal.pone.0079717 – volume: 3 start-page: 19 issue: Supple year: 2013 ident: 32_CR15 publication-title: Kidney Int – volume: 365 start-page: 981 year: 2011 ident: 32_CR42 publication-title: N Engl J Med doi: 10.1056/NEJMoa1107039 – volume: 158 start-page: 629 year: 2009 ident: 32_CR41 publication-title: Am Heart J doi: 10.1016/j.ahj.2009.06.031 – volume: 46 start-page: 515 year: 2016 ident: 32_CR27 publication-title: Korean Circ J doi: 10.4070/kcj.2016.46.4.515 – volume: 52 start-page: 964 year: 2012 ident: 32_CR6 publication-title: J Clin Pharmacol doi: 10.1177/0091270011409231 – volume: 361 start-page: 1139 year: 2009 ident: 32_CR17 publication-title: N Engl J Med doi: 10.1056/NEJMoa0905561 – volume: 364 start-page: 806 year: 2011 ident: 32_CR43 publication-title: N Engl J Med doi: 10.1056/NEJMoa1007432 – volume: 75 start-page: 2749 year: 2011 ident: 32_CR31 publication-title: Circ J doi: 10.1253/circj.CJ-11-1134 – volume: 30 start-page: 776 year: 2010 ident: 32_CR8 publication-title: Pharmacotherapy doi: 10.1592/phco.30.8.776 – volume: 96 start-page: 2455 year: 1997 ident: 32_CR2 publication-title: Circulation doi: 10.1161/01.CIR.96.7.2455 – volume: 367 start-page: 625 year: 2012 ident: 32_CR5 publication-title: N Engl J Med doi: 10.1056/NEJMoa1105594 – volume: 374 start-page: 525 year: 2009 ident: 32_CR28 publication-title: Lancet doi: 10.1016/S0140-6736(09)61340-4 – volume: 33 start-page: 2821 year: 2012 ident: 32_CR9 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehs274 – volume: 28 start-page: 1404 year: 2013 ident: 32_CR35 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfs607 – volume: 75 start-page: 2767 year: 2011 ident: 32_CR29 publication-title: Circ J doi: 10.1253/circj.CJ-11-0780 – volume: 55 start-page: 2319 year: 2010 ident: 32_CR24 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2010.02.029 – volume: 34 start-page: 3572 year: 2013 ident: 32_CR10 publication-title: Eur Heart J doi: 10.1093/eurheartj/eht328 – volume: 28 start-page: 1396 year: 2013 ident: 32_CR34 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gft006 – volume: 55 start-page: 622 year: 2010 ident: 32_CR44 publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2010.02.337 – volume: 137 start-page: 102 year: 2009 ident: 32_CR20 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2008.06.029 – volume: 271 start-page: 840 year: 1994 ident: 32_CR25 publication-title: JAMA doi: 10.1001/jama.1994.03510350050036 – volume: 10 start-page: e0143205 year: 2015 ident: 32_CR32 publication-title: PLoS ONE doi: 10.1371/journal.pone.0143205 – volume: 53 start-page: 982 year: 2009 ident: 32_CR37 publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2008.12.034 – volume: 127 start-page: 224 year: 2013 ident: 32_CR11 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.107128 – volume: 119 start-page: 1229 year: 2017 ident: 32_CR12 publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2017.01.005 – volume: 102 start-page: 1056 year: 2008 ident: 32_CR40 publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2008.06.018 – volume: 42 start-page: 1050 year: 2003 ident: 32_CR4 publication-title: Hypertension doi: 10.1161/01.HYP.0000102971.85504.7c – volume: 33 start-page: 278 year: 1985 ident: 32_CR33 publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.1985.tb07117.x |
SSID | ssj0028591 |
Score | 2.2503114 |
Snippet | Direct oral anti-coagulants (DOACs) have been used in patients with non-valvular atrial fibrillation (AF), and renal function evaluation using the CCr... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 451 |
SubjectTerms | Adult Age Aged Aged, 80 and over Atrial Fibrillation - epidemiology Atrial Fibrillation - physiopathology Cardiac arrhythmia Creatinine - blood Cross-Sectional Studies Family medical history Female Gender Glomerular Filtration Rate Humans Hypertension Japan - epidemiology Kidney - physiopathology Male Middle Aged Prevalence Risk Factors Young Adult |
Title | Estimated glomerular filtration ratio is a better index than creatinine clearance (Cockcroft–Gault) for predicting the prevalence of atrial fibrillation in the general Japanese population |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29559690 https://www.proquest.com/docview/2049881417 https://www.proquest.com/docview/2016532685 |
Volume | 41 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1348-4214 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0028591 issn: 0916-9636 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVLSH databaseName: SpringerLink Journals customDbUrl: mediaType: online eissn: 1348-4214 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0028591 issn: 0916-9636 databaseCode: AFBBN dateStart: 20050101 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1348-4214 dateEnd: 20241001 omitProxy: true ssIdentifier: ssj0028591 issn: 0916-9636 databaseCode: 7X7 dateStart: 20150101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1348-4214 dateEnd: 20241001 omitProxy: true ssIdentifier: ssj0028591 issn: 0916-9636 databaseCode: BENPR dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NatwwEBZtAqWXkv5vmoYp9NAWRC1bkqVTSMOmIZBQSgN7M7Ish4Wtvd2fe96hz9OX6ZNkRtZu6KE5mcWyBTufZr7RyN8w9r6lNEPVOW9aiQmK0oHbulE8lJbUZbwIgRLFi0t9diXPJ2qSNtyW6VjlxidGR930nvbIMUmX1hghRXk0_8WpaxRVV1MLjYdsVyBVIVSXk7uEi7TZotae0ByBpjdVzcJ8XspY1cyE4YjrnOt_49J_yGYMOqd77Elii3A8mPcpexC6Z-zRRaqHP2d_xrhCkXOGBq5n_c-woEOl0E5nSQwX4gWmS3BQxw93IMojAm2Yw0AYO3wTeOoeQQCADyfoIaN3_nvz-6tbz1YfAYktzBc0Kx2SxocD_USMkluAvgUXm3_gxPWCuhjFqaddHHg96FrDOUZl6nYJ823LsBfs6nT84-SMp4YM3BfSrrizKkdG45uyyK10TRZE8HWJFMA7bTAaYmjLnDQKaUVhMffKvSoxTa0LQd_zuuIl2-n6LrxmQLYJZWu1qgspna8z6Vwjg0E66kTrRyzbmKPySa2cmmbMqlg1L0w1WLBCC5K-aV7pEfu0fWQ-SHXcN_hgY-MqrdpldYexEXu3vY3rjYoo-B_1axojtELOa9SIvRqwsZ0tJzk_bbP9-1_-hj3OI_BoL-eA7awW6_AWqc2qPoz4PWS7X8aX377fAsii-YA |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LbtQwFLVKkYAN4s1AgYsEEiBZJI7tJAuEUGmZPqarVppdsB2nGmmaTOchxI5_4D_4A36GL-FeJ5mKBd11FUXxQ8q9vg9f-xzGXlWUZigreFlJTFCU9jy3peI-zQldxsXeU6I4OtLDE7k_VuMN9qu_C0PHKnubGAx12TjaI8ckXeZZFss4_Tg758QaRdXVnkKjVYsD__0bpmyLD3ufUb6vhdjdOd4e8o5VgLtE5ktuciXQLbsyTUQuTRn52Duboh9zRmdo0tE-R0ZmCn1jkmMCIZxKMdeySUyXUk2C415j12USScLqT8cXCR5hwQVsv1hzVGzdV1GT7P1ChipqFGcc15Hg-l8_-J_gNji53TvsdhedwqdWne6yDV_fYzdGXf39Pvu9gxYBY1xfwum0OfNzOsQK1WTage9CeMBkAQZsuCgEAY4RaIMe2gC1xpHAEVsFKRy82UaLHLzBnx8_v5jVdPkWMJCG2ZxmpUPZ2NnTK64JMkPQVGAC2QhObOfEmhSmntSh4WmLow37GAUQuybM1hRlD9jJlYjqIdusm9o_ZkCy8WmVa2UTKY2zkTSmlD7D8NfElRuwqBdH4Tp0dCLpmBahSp9kRSvBAiVIeKqi0AP2bt1l1kKDXNZ4q5dx0VmJRXGh0wP2cv0Z1zcVbfAfNStqE2uFMXamBuxRqxvr2QTBB-o8enL54C_YzeHx6LA43Ds6eMpuiaCEtI-0xTaX85V_hmHV0j4Pugzs61Uvnr8IyzEx |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La9VAFB5qheJGfPfWqkdQUGFoMq8kCxFpe-3DFhcW7i5OJpNy4Zrc3gfizv_gvxH8M_4Sz5kkt7iwu65CyDwg5z3nzHcYe1FRmKELwctKYYCijedZUWruk4zQZVzsPQWKJ6fm4EwdjfRojf3q78JQWWWvE4OiLhtHZ-QYpKssTWMVJztVVxbxaW_4bnrBqYMUZVr7dhotixz7798wfJu_PdxDWr8UYrj_efeAdx0GuJMqW3CbaYEm2pWJFJmyZeRj74oEbZqzJkX1jro6sirVaCdlhsGEcDrBuKuQMV1QtRLXvcFuJlJJKidLRpfBHuHCBZy_2HBkctNnVGW6M1choxrFKUeZEtz8axP_4-gGgze8w253niq8b1nrLlvz9T22cdLl4u-z3_uoHdDf9SWcT5qvfkYFrVCNJx0QL4QHjOdgoQiXhiBAMwId1kPrrNa4EjjqXEHMB692UTsHy_Dnx88PdjlZvAZ0qmE6o12pQBsne3pF-SCVBE0FNjQewY2LGXVQCluP6zDwvMXUhiP0CKjTJkxX7coesLNrIdVDtl43td9kQLTxSZUZXUilrCsiZW2pfIqusI0rN2BRT47cdUjp1LBjkoeMvUzzloI5UpCwVUVuBuzNasq0hQm5avB2T-O80xjz_JK_B-z56jPKOiVw8B81SxoTG43-dqoH7FHLG6vdBEEJmizaunrxZ2wDxSb_eHh6_JjdEoEH6Uhpm60vZkv_BD2sRfE0sDKwL9ctO38BX3E1bA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Estimated+glomerular+filtration+ratio+is+a+better+index+than+creatinine+clearance+%28Cockcroft-Gault%29+for+predicting+the+prevalence+of+atrial+fibrillation+in+the+general+Japanese+population&rft.jtitle=Hypertension+research&rft.au=Yonezawa%2C+Yutaka&rft.au=Horinaka%2C+Shigeo&rft.au=Shirakawa%2C+Chiaki&rft.au=Kogure%2C+Yoshio&rft.date=2018-06-01&rft.eissn=1348-4214&rft.volume=41&rft.issue=6&rft.spage=451&rft_id=info:doi/10.1038%2Fs41440-018-0032-6&rft_id=info%3Apmid%2F29559690&rft.externalDocID=29559690 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0916-9636&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0916-9636&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0916-9636&client=summon |